HIV Protease Inhibitors

All categories
DBCAT000552Therapeutic category

Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. A DrugBank category of 15 drugs. 11 of them are approved.

Part of
Antiviral Agents
Also known as
Antiretroviral Protease Inhibitors · HIV-Protease Inhibitors · Inhibitors, HIV Protease · Protease Inhibitors, HIV
Drugs

What you can answer from here — as of August 16, 2018

15DrugsEach linked to its full drug card
Listed above
12Drug targetsEvery drug–target pair in the class, with bond type
Sign in
1,172Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in
1SubcategoryNarrower classes within this one
Sign in

Which targets do HIV Protease Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In